This investigation explains in detail how TGF-β anti-growth signaling is blocked in BCR-ABL1-positive CML, and for the first time identified the direct impact of oncoproteins on the TGF-β signaling pathway in leukemia. Here, TGFB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.